Menu
close
What is XLH and more
Treatment
Treatment
Dentistry
Resources
Genetics
Latest News
Contact Us
The Work We Do
Supporter Events
Events
About Us
XLH UK policy on working with pharmaceutical and medical device companies
Privacy Policy
Donate
Donate
Post Slider
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout point of using.
Home
Post Slider
Post Slider
Modern Style
Publication
I Am Number Seventeen
Conference, News
Webinar on the unrecognised burden of XLH in adults
Publication, Research, Treatment
Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
News, Publication
XLH UK features in the New Scientist magazine
Publication, Research
Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance
News, Treatment
Scottish Medicines Consortium enables access to burosumab for treating X-linked hypophosphataemia
Call to Action, News
Help those in Scotland and Ireland access new treatment
Conference, Research
International Conference on Children’s Bone Health, 2019
News, Treatment
NICE u-turn approves first therapy for children with XLH
Post Slider
Modern Style 2
Publication
I Am Number Seventeen
Conference, News
Webinar on the unrecognised burden of XLH in adults
Publication, Research, Treatment
Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
News, Publication
XLH UK features in the New Scientist magazine
Publication, Research
Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance
News, Treatment
Scottish Medicines Consortium enables access to burosumab for treating X-linked hypophosphataemia
Call to Action, News
Help those in Scotland and Ireland access new treatment
Conference, Research
International Conference on Children’s Bone Health, 2019
News, Treatment
NICE u-turn approves first therapy for children with XLH